Agiliti, Inc. (AGTI) Research
Agiliti, Inc. delivers comprehensive healthcare technology management and service solutions across the United States. Its offerings include robust on-site managed services, which encompass the organization, reprocessing, and logistical coordination of medical equipment directly at client facilities and integrated delivery networks. These programs are designed to proactively adapt equipment inventories and accessibility to align with changing patient volumes and care intensity. Furthermore, the company provides expert clinical engineering services, covering the maintenance, repair, and corrective actions for a wide array of medical devices, ranging from general biomedical apparatus to advanced diagnostic imaging and surgical equipment. These engineering solutions are available both as supplemental support and through fully outsourced contracts. Agiliti also features equipment rental solutions, primarily supplying general biomedical, specialty, and surgical equipment for short-term needs, peak demand periods, or on a per-case basis. The firm serves a broad spectrum of healthcare providers, including acute care hospitals, health systems, integrated delivery networks, and various alternative care sites. Established in 1939, Agiliti, Inc. maintains its corporate headquarters in Eden Prairie, Minnesota.
Market snapshot
- Symbol
- AGTI
- Price
- $10.05
- Day change
- -0.50%
- Market cap
- $1.4B
- P/E ratio
- -69.66x
- 52-week range
- 5.07-18.61
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Analyst price target
- $20.00
Peer companies
Recent insider activity
- HARRIS C MARTIN — D-Return (19150 shares) on 2024-05-07
- PATRICK DIANE B. — D-Return (36901 shares) on 2024-05-07
- FRIEDMAN DARREN M. — D-Return (11800 shares) on 2024-05-07
- FRIEDMAN DARREN M. — D-Return (50909 shares) on 2024-05-07
- FRIEDMAN DARREN M. — D-Return (55703 shares) on 2024-05-07
Open Agiliti, Inc. (AGTI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.